Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Safety and Effect in TB Patients With NAC

NCT02889757 is registered in ClinicalTrials.gov with Far Eastern Memorial Hospital as lead sponsor.

NCT NCT02889757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02889757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Safety and Effect in TB Patients With NAC
Lead sponsor
Far Eastern Memorial Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2017
Completion date
June 30, 2019
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

protective effect in tb-dih, tb-dih means: drug induced liver function abnormalities